Purchase Order 75D30119P05472
Award Date 6/20/19
Potential Completion Date 7/20/19
Potential Value $140K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $55,000.00 firm fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. This contract has a completion date of May 21, 2024. Qiagen is a foreign-owned, for-profit manufacturer that has provided a range of products and services to support federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Qiagen, LLC, a division of the international provider of sample and assay technologies Qiagen N.V. The $38,760.96 contract is for laboratory supplies to be delivered by November 1, 2022. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under past...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed-price purchase order to Qiagen, LLC, a division of Qiagen N.V., for the acquisition of QIAGEN equipment and reagents. The contract, valued at $134,538.38, does not have a set-aside designation. Qiagen N.V. is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academic research. The company has a history of supporting federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $133,979.07 firm fixed price purchase order to Qiagen, LLC, a division of the international life sciences company Qiagen N.V. The contract is for the provision of laboratory equipment and furniture, with a completion date of November 15, 2023. Qiagen is a manufacturer of products and provider of services to support federal agencies' biomedical research, public health, law enforcement, and...
- This is a $148,157.70 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for other unspecified functions and does not have a set-aside designation. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs under...
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $60,250.00 firm fixed price purchase order contract to Qiagen, LLC, a division of the parent company Qiagen N.V. The contract has an ultimate completion date of September 28, 2024 and was awarded on September 29, 2023. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academics. This contract does not have a set-aside designation. Qiagen has...
- This is a $14,288 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Qiagen, LLC, a division of Qiagen N.V. The contract has a period of performance from April 1, 2025 to March 31, 2026 for Qiagen to provide laboratory services under the IP0023 Statement of Work. No set-aside designation was used. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, and other applications. The company...
- This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $57,348.26 firm fixed-price purchase order contract to Qiagen, LLC, a division of the international provider Qiagen N.V., for QIACUITY equipment and maintenance services. This contract does not have a set-aside designation. Qiagen has a history of providing products and services, such as DNA/RNA extraction kits, next-generation sequencing, and bioinformatics software, to support federal agencies'...
- This firm fixed-price purchase order contract was awarded by the Office of the Chief Operating Officer (part of the Department of Health and Human Services) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The $80,047.85 contract is for the delivery of Qiagen's sample and assay technologies, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, and related bioinformatics software. Qiagen has provided these types of...